Skip to main content
. 2019 May 9;20(9):2292. doi: 10.3390/ijms20092292

Figure 3.

Figure 3

FGF23 levels in individuals with COPD, subgrouped according to their use of cardiovascular medication. Dot plot showing plasma FGF23 levels in individuals with COPD, who receive no cardiac medications (no meds), or regularly take ACE inhibitors (ACEI), beta blockers (BB) or both (ACEI + BB), showing no significant differences in FGF23 levels using multiple comparison ANOVA.